Keratinocyte cytokine and chemokine production pathways

Keratinocyte cytokine and chemokine production pathways" refers to the collective cellular signaling routes by which keratinocytes, the main cell type in the epidermis, synthesize and release a large repertoire of cytokines (such as IL-1β, IL-6, IL-18, the IL-20 family, TSLP, IL-33, and IL-25) and chemokines (such as CCL17, CCL20, CCL22, CCL27, CXCL9, CXCL10, CXCL11)[1][2][3][4][5]. These pathways are activated in response to diverse stimuli, including pathogens, injury, environmental stress, and pro-inflammatory mediators[1][2][3][4][5]. The resulting cytokines and chemokines play crucial roles in recruiting and activating immune cells, modulating T cell responses, orchestrating cutaneous inflammation, and maintaining or disrupting the epidermal barrier[1][2][3][4][5]. Dysregulation of these pathways is implicated in diseases such as atopic dermatitis, psoriasis, and infection[2][3][4][5]. This term, however, does not specify a single protein or druggable target, but rather a complex network of interrelated signaling molecules and responses. In summary, the phrase provided refers to an important aspect of cutaneous immunobiology rather than a discreet molecular target suitable for drug binding or selective pharmacological intervention.